In addition, AKT activation in hypoxic regions of breast tumors has been linked with poor patient prognosis, whereas AKT inhibition may improve radiotherapy response in p53-deficient tumors, and for this purpose further studies are needed to evaluate the role of INPP5D in the radioresistance process. This evidence concerns the gene TP53 and breast neoplasm.